Do ochratoxin A and gliotoxin impair mitochondria and increase glutathione demand?

Ochratoxin A (OTA) and gliotoxin are potent mycotoxins capable of inducing severe cellular damage. Research confirms that both toxins target mitochondria and trigger cascades that deplete essential cellular defenses, particularly in sensitive populations where physiological reserves may be limited.

Mechanistic explanations

• Mitochondrial impairment: Ochratoxin A directly disrupts the mitochondrial electron transport chain (ETC), resulting in a loss of mitochondrial membrane potential ($\Delta\Psi_m$), decreased ATP synthesis, and the opening of mitochondrial permeability transition pores (mPTP) which triggers cytochrome c release and apoptosis. Gliotoxin acts as a redox-active disulfide toxin, inducing broad thiol modification of mitochondrial proteins, leading to global energetic failure.
• Oxidative stress generation: Both toxins dramatically increase reactive oxygen species (ROS) and lipid peroxidation (measured via malondialdehyde, or MDA). Gliotoxin undergoes continuous redox cycling, reacting with intracellular thiols to generate superoxide and hydrogen peroxide.
• Increased glutathione demand and depletion: Under this heightened oxidative burden, reduced glutathione (GSH) is rapidly consumed by glutathione peroxidase (GPx) to neutralize peroxides. Gliotoxin directly depletes GSH via disulfide-thiol exchange. Furthermore, high doses of OTA impair the NRF2 antioxidant response pathway and downregulate key glutathione-system enzymes, including glutathione synthetase (GSS) and glutathione reductase (GSR), creating an acute deficit in cellular redox-scavenging capacity.

Clinical implications

• Susceptibility and oxidative burden: In older adults, baseline mitochondrial efficiency and glutathione synthesis naturally decline. Exposure to OTA or gliotoxin further exhausts these vulnerable antioxidant pools, potentially exacerbating systemic oxidative stress and mitochondrial decay.
• Therapeutic targets: Supporting the glutathione system—either by providing precursors like N-acetylcysteine (NAC) or upregulating NRF2-mediated antioxidant defenses—represents a critical therapeutic pathway to mitigate mycotoxin-induced mitochondrial dysfunction and cellular injury.

Bottom line

• Both Ochratoxin A and gliotoxin significantly inhibit mitochondrial function and elevate oxidative stress through direct respiratory chain disruption and redox cycling. This dual insult rapidly depletes reduced glutathione pools and increases cellular glutathione demand, underscoring the importance of antioxidant preservation during mycotoxin exposure.